Catheter Precision VTAK
NYSE VTAK
$0.20 -0.01 (-4.63%)
As of: Aug 20, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Capital Expenditures Growth (3y) (2020 - 2024)

Catheter Precision (VTAK) Capital Expenditures Growth (3y) (2020 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -0.66%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 9.94%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 8.89%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 10.89%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 11.78%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 12.81%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 12.62%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 19.51%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 9.52%
10 Catheter Precision 564,834.50 -1.27 Mn 98,000.00 -9.14%

Historic Data

Download Data
DateValue
Jun 30, 2024 -9.03%
Dec 31, 2023 77.58%
Sep 30, 2023 -64.84%
Jun 30, 2023 -1.61%
Mar 31, 2023 9.74%
Dec 31, 2022 -29.25%
Dec 31, 2021 -27.18%
Sep 30, 2021 -35.35%
Jun 30, 2021 -12.09%
Mar 31, 2021 -44.97%
Dec 31, 2020 -26.38%